Gastro Hepatic Pack Treatment for the improvement in Type II Diabetes Mellitus patients.
Phase 2
- Conditions
- Health Condition 1: E119- Type 2 diabetes mellitus without complications
- Registration Number
- CTRI/2024/02/063097
- Lead Sponsor
- Dr M Mownika
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Type 2 Diabetes mellitus patients with increased HbA1C level.
Exclusion Criteria
Patients with diabetic systemic complications like diabetic neuropathy, retinopathy & nephropathy. Patients with spinal injury and hernia patients.
Patients who did abdominal and spinal surgery for past year.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Assessment of Glycated Haemoglobin (HbA1C).Timepoint: Assessment of Glycated Haemoglobin (HbA1C) will be taken before starting of the study and after completion of the study (4 months).
- Secondary Outcome Measures
Name Time Method Assessment of SGOT & SGPT.Timepoint: Assessment of SGOT & SGPT will be taken before starting of the study and after completion of the study (4 months).